Overview
Michel Velez is an Oncologist in Fort Lauderdale, Florida. Dr. Velez is highly rated in 6 conditions, according to our data. His top areas of expertise are Inflammatory Breast Cancer, Angiosarcoma, Breast Cancer, and Paget Disease of the Breast.
His clinical research consists of co-authoring 9 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- MEDICARE MAPD
- OTHER MEDICARE
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- EPO
- PPO
- INSURANCE PLAN
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE ASSISTANCE PROGRAM
- MEDICARE MAPD
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- EPO
- HMO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
4725 N Federal Hwy, Fort Lauderdale, FL 33308
6400 Sanger Rd Ste A-2400, Orlando, FL 32827
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
3 Clinical Trials
Baptist Health Miami Cancer Institute
Manmeet Ahluwalia is an Oncologist in Miami, Florida. Dr. Ahluwalia is highly rated in 25 conditions, according to our data. His top areas of expertise are Brain Tumor, Glioblastoma, Astrocytoma, and Glioma. Dr. Ahluwalia is currently accepting new patients.
Memorial Cancer Institute
Luis Raez is a Hematologist and an Oncologist in Pembroke Pines, Florida. Dr. Raez is highly rated in 13 conditions, according to our data. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, Lung Adenocarcinoma, and Tissue Biopsy. Dr. Raez is currently accepting new patients.
Office
Brian Slomovitz is an Oncologist in Miami Beach, Florida. Dr. Slomovitz is highly rated in 15 conditions, according to our data. His top areas of expertise are Endometrial Cancer, Ovarian Cancer, Cervical Cancer, Hysterectomy, and Lymphadenectomy.
Frequently Asked Questions about Dr. Michel Velez
How do I make an appointment with Dr. Michel Velez?
You can book an appointment with Dr. Michel Velez by calling their office at 954-542-7700. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Michel Velez a top-rated expert for Inflammatory Breast Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Michel Velez is classified as an Advanced expert for Inflammatory Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Michel Velez specialize in?
While Dr. Michel Velez is a Oncology, they have specific expertise in Inflammatory Breast Cancer, Angiosarcoma, and Breast Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Michel Velez participate in research or clinical trials?
Yes. Dr. Michel Velez has published 9 articles and abstracts on conditions like Inflammatory Breast Cancer. You can view a list of Dr. Michel Velez's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Michel Velez accept my insurance?
Dr. Michel Velez accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 954-542-7700 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- AngiosarcomaDr. Velez isAdvanced. Learn about Angiosarcoma.
- Breast CancerDr. Velez isAdvanced. Learn about Breast Cancer.
- Familial Colorectal CancerDr. Velez isAdvanced. Learn about Familial Colorectal Cancer.
- Inflammatory Breast CancerDr. Velez isAdvanced. Learn about Inflammatory Breast Cancer.
- Non-Small Cell Lung Cancer (NSCLC)
- Paget Disease of the BreastDr. Velez isAdvanced. Learn about Paget Disease of the Breast.
- Experienced
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Velez isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Adult Soft Tissue SarcomaDr. Velez isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Velez isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung Cancer